Safety and effectiveness of Neuroform Atlas stent-assisted coil embolization for ruptured intracranial aneurysms
10.7461/jcen.2024.E2024.04.006
- Author:
Kyu Sik HEO
1
;
Jung Ho KO
Author Information
1. Department of Neurosurgery, Dankook University College of Medicine, Cheonan, Republic of Korea
- Publication Type:Clinical Article
- From:Journal of Cerebrovascular and Endovascular Neurosurgery
2024;26(4):373-382
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:The treatment outcomes of ruptured intracranial aneurysms using the Neuroform Atlas stent were evaluated.
Methods:This study represents a retrospective review that included patients who underwent endovascular treatment for ruptured aneurysms at a single institution. Between January 2018 and September 2022, endovascular treatments including simple coiling or Neuroform Atlas stent-assisted coil embolization were performed in 191 patients with ruptured intracranial aneurysms.
Results:Intraprocedural rupture was observed in 11 (8.7%) patients in the Simple Coiling (SC) group, which was slightly higher than that in 4 (6.3%) patients in the Neuroform Atlas stent-assisted coiling (NASAC) group (p=0.241). However, Thromboembolic event (TEE) was slightly more prevalent in the NASAC group, with 4 (6.3%) cases as compared to the 5 (3.9%) cases in the SC group (p=0.235). The retreatment rate was slightly higher in the SC group, with 19 (26.4%) patients as compared to the 10 patients (22.2%) in the NASAC group (p=0.342).
Conclusions:The use of the Neuroform Atlas stent (NAS) for ruptured aneurysms might be safe and effective.